BEAM
Beam Therapeutics Inc
NASDAQ: BEAM · HEALTHCARE · BIOTECHNOLOGY
$29.38
-3.86% today
Updated 2026-04-29
Market cap
$3.02B
P/E ratio
—
P/S ratio
21.60x
EPS (TTM)
$-0.81
Dividend yield
—
52W range
$15 – $36
Volume
2.1M
Beam Therapeutics Inc (BEAM) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | $0.00 | $18000.00 | $24000.00 | $51.84M | $60.92M | $377.71M | $63.52M | $139.74M |
| Revenue growth (YoY) | — | — | — | +33.3% | +215916.7% | +17.5% | +520.0% | -83.2% | +120.0% |
| Cost of revenue | $11000.00 | $33.87M | $54.62M | $103.18M | $232.13M | $311.59M | $437.38M | $367.56M | $22.29M |
| Gross profit | $-11000.00 | $-33.87M | $-54.60M | $-103.16M | $-180.29M | $-250.67M | $377.71M | $-304.04M | $117.45M |
| Gross margin | — | — | -303338.9% | -429812.5% | -347.8% | -411.5% | 100.0% | -478.7% | 84.0% |
| R&D | $5.86M | $33.87M | $54.62M | $103.18M | $387.09M | $311.59M | $437.38M | $367.56M | $409.62M |
| SG&A | $2.02M | $11.87M | $20.55M | $29.61M | $57.22M | $87.81M | $116.81M | $111.53M | $113.82M |
| Operating income | $-8.60M | $-45.74M | $-75.15M | $-132.76M | $-392.46M | $-338.48M | $-176.49M | $-415.57M | $-383.69M |
| Operating margin | — | — | -417522.2% | -553166.7% | -757.0% | -555.6% | -46.7% | -654.3% | -274.6% |
| EBITDA | $-8.58M | $-45.09M | $-71.65M | $-128.03M | $-230.06M | $-324.33M | $-146.95M | $-393.64M | $-29.92M |
| EBITDA margin | — | — | -398061.1% | -533437.5% | -443.8% | -532.4% | -38.9% | -619.7% | -21.4% |
| EBIT | $-8.60M | $-45.74M | $-75.15M | $-132.76M | $-237.51M | $-338.48M | $-176.49M | $-415.57M | $-36.26M |
| Interest expense | $0.00 | $0.00 | $187000.00 | $1.57M | $9000.00 | $15.30M | $46.68M | $49.09M | $43.73M |
| Income tax | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-8.73M | $-115.26M | $-78.33M | $-194.59M | $-370.64M | $-289.09M | $-132.53M | $-376.74M | $-79.99M |
| Net income growth (YoY) | — | -1220.3% | +32.0% | -148.4% | -90.5% | +22.0% | +54.2% | -184.3% | +78.8% |
| Profit margin | — | — | -435144.4% | -810800.0% | -714.9% | -474.5% | -35.1% | -593.1% | -57.2% |